Leukemia-Lymphoma

Immunotherapies offer promise for Hodgkin lymphomaResearchers see promising early clinical trials with checkpoint-inhibitor therapies, opening the door for checkpoint-blockade combo therapies.
Achieving balance: Providing high-value cancer care
Achieving balance: Providing high-value cancer careHow plans can achieve the right balance between cost and outcomes